05/03/2026
The FDA has approved the drug Auvelity for the treatment of agitation in adults with Alzheimer's dementia.
The extended-release tablet is the first FDA-approved medication for this condition that is not an anti-psychotic.
Anti-psychotics carry serious risks including stroke, sedation and increased death in older adults, according to the FDA. Having a non-antipsychotic option may be safer for patients, experts say.
Read more:https://abcnews.visitlink.me/1aH3K7